NYSE$AHR
American Healthcare REIT Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
AHR Q2 2023 — $9.7M revenue
Our accompanying condensed consolidated financial statements reflect all adjustments which are, in our view, of a normal recurring nature and necessary for a fair presentation of our financial positio. American Healthcare REIT Inc reported Q2 2023 results. Net income of $2.2M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $9.7M.
- Net income: $2.2M.
- Operating income: $41K.
Headline financials
Revenue & EPS history
American Healthcare REIT Inc · Revenue · Quarterly
$411M
Revenue by segment
American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024
- ISHC$423M—78.0%
- SHOP$73.5M—13.6%
- Outpatient Medical$33.3M—6.1%
- Triple-Net Leased$12.6M—2.3%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 11 quarterly earnings reports · overlaid with Q2 2023
+1.8%
Avg return
Earnings day
+2.2%
Avg return
5 days after
+3.9%
Avg return
30 days after
64%
7 / 11 earnings
Positive
+8.3%
Q1 2025
Best reaction
-2.1%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.3% | +4.1% | -4.2% | |
| Q4 2025 | -2.1% | -2.5% | -11.4% | |
| Q3 2025 | +3.0% | -0.1% | +4.6% | |
| Q2 2025 | +1.3% | +2.0% | +7.2% | |
| Q1 2025 | +8.3% | +6.1% | +10.2% | |
| Q4 2024 | -1.3% | +0.7% | +0.8% | |
| Q3 2024 | +1.2% | +2.7% | +7.1% | |
| Q2 2024 | +3.3% | +3.6% | +35.1% | |
| Q1 2024 | -0.1% | +3.5% | +6.2% | |
| Q2 2023 | +2.8% | +1.3% | -6.8% | |
| Q4 2023 | -0.8% | +3.2% | -5.9% | |
| Q3 2023 | — | — | — | |
| Q1 2023 | — | — | — | |
| Q4 2022 | — | — | — | |
| Q3 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — | |
| Q4 2021 | — | — | — | |
| Q3 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro